Affordable Access

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Authors
Type
Published Article
Journal
Clinical Cancer Research
1078-0432
Publisher
American Association for Cancer Research (AACR)
Publication Date
Volume
13
Issue
7
Pages
2038–2045
Identifiers
PMID: 17404084
Source
Medline

Abstract

Statistics

Seen <100 times